Anti-idiotype antibody generation and application in antibody drug discovery
Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR), making them useful in pharmacokinetic (PK) and pharmacodynamic (PD) studies to specifically measure circulating antibody drug concentrations. They also serve as positive controls or reference standards in immune response (IR) assays. Join this interactive webinar to learn about the different types of anti-IDs and their use in PK/PD and immunogenicity assays. We will review the obstacles and solutions surrounding the generation of highly sensitive, highly specific anti-IDs with examples from vaccine and antibody drug development case studies.
|Anti Idiotypic Antibodies: A Powerful Tool for Antibody Drug Studies|
|Therapeutic hybridoma development||DNA immunization service||Anti-idiotypic antibody service|